Overview Financials News + Filings Key Docs Insiders
|
In millions, except per share items | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 | Dec-31-07 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Revenues | 2.1 | 1.7 | -7.0 | -0.8 | 9.1 | 0.0 | 0.0 | 0.0 |
Revenue growth | 23.3% | -124.0% | 812.0% | -108.4% | | | | |
Cost of goods sold | 1.5 | 1.6 | -5.4 | -4.7 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross profit | 0.5 | 0.1 | -1.5 | 3.9 | 9.1 | 0.0 | 0.0 | 0.0 |
Gross margin | 26.3% | 4.9% | 22.2% | -512.9% | 100.0% | | | |
Selling, general and administrative [+] | 1.4 | 1.4 | 1.7 | 2.3 | 1.8 | | | |
Sales and marketing | | | | 0.4 | 0.3 | | | |
General and administrative [+] | 1.4 | 1.4 | 1.7 | 1.9 | 1.6 | 0.0 | 0.0 | 0.0 |
General and administrative expenses | 1.4 | 1.4 | 1.7 | 1.9 | 1.6 | | | |
Professional fees | 0.4 | 0.5 | 0.9 | 1.1 | 1.0 | | | |
Other operating expenses | -0.8 | -0.7 | 6.7 | 7.9 | 4.6 | | | |
EBIT [+] | 0.0 | -0.6 | -9.9 | -6.3 | 2.7 | 0.0 | 0.0 | 0.0 |
EBIT growth | -105.5% | -93.5% | 57.3% | -333.9% | | | | |
EBIT margin | 1.7% | -38.2% | 141.7% | 821.6% | 29.5% | | | |
Non-recurring items [+] | 0.1 | 0.1 | 0.6 | -0.1 | 0.1 | | | |
Unusual expense | 0.1 | 0.1 | 0.6 | -0.1 | 0.1 | | | |
Interest income | 0.2 | 0.3 | 0.6 | 0.5 | 0.1 | 0.1 | 0.0 | |
Interest income | 0.2 | 0.3 | 0.6 | 0.5 | 0.1 | 0.1 | 0.0 | |
Other income (expense), net [+] | | | | | | -0.1 | 0.0 | |
Gain (loss) on investments | -0.1 | -0.2 | 0.0 | -0.7 | 0.0 | | | |
Pre-tax income | 0.1 | -0.5 | -9.9 | -5.6 | 2.7 | 0.0 | 0.0 | 0.0 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | | | |
Net income | 0.1 | -0.5 | -9.9 | -5.6 | 2.7 | 0.0 | 0.0 | 0.0 |
Net margin | 6.8% | -28.6% | 141.4% | 735.6% | 29.5% | | | |
|
Basic EPS | | | | | $17.99 | | | |
Diluted EPS | | | | | $17.99 | | | |
|
Shares outstanding (basic) | | | | | 0.1 | | | |
Shares outstanding (diluted) | | | | | 0.1 | | | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|